The New Home Company is in the homebuilding and construction industry and trades as part of the consumer cyclical sector. The company CEO is H. Lawrence Webb. The New Home Co Inc is a homebuilding company. It is engaged in the design, construction and sale of consumer-driven homes in metropolitan areas within select growth markets in California and Arizona.

Previous Intraday Performance:

The NWHM shares had a previous change of 2.37% which opened at 4.10 and closed at 4.32. It moved to an intraday high of 4.36 and a low of 4.04.

SeekingAlpha:  Third Avenue Management – The New Home Company

Historical Performance:

Over the last five trading days, NWHM shares returned -3.57% and in the past 30 trading days it returned -12.73%. Over three months, it changed -22.72%. In one year it has changed -57.27% and within that year its 52-week high was 10.59 and its 52-week low was 4.04. NWHM stock is 6.93% above its 52 Week Low.

Our calculations result in a 200 day moving average of 6.79 and a 50 day moving average of 4.84. Right now, NWHM stock is trading -36.37% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

SeekingAlpha:  Third Avenue Management – The New Home Company


The company has a market cap of $86.6m with 20.0m shares outstanding and a float of 18.6m shares. Trading volume was 267,641 shares and has experienced an average volume of 68,634 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for The New Home Company was -0.68 which ended on 31st of December 2018.

Base on our calculations, the intrinsic value per share is 16.65, which means it might be undervalued and has a margin of safety of 74.05%

The next earnings report will be: 06-03-2019

The long-term trend of the EPS is a vital number as it helps understand the future potential of The New Home Company; it is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -9.20% over the last twelve months.

Indicators Also to Watch:

Based on the latest filings, there is 92.90% of institutional ownership. Short-interest was 1,212,187, which was 6.05% of shares outstanding. The short-interest ratio or days-to-cover ratio was 18.46. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.

I calculated the beta to be 1.80

PR Newswire:  Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Superior Dose-Related Target Engagement Activity to PTG-100 in Single Ascending Dose Phase 1 Study

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is -6.57%, return on assets is -2.43%, profit margin is -2.36%, price-to-sales is 0.13 and price-to-book is 0.36.

Company Score Card:

Results are out of six:
 3  : Growth Expectations Result
 2  : Financial Safety Result
 0  : Past Performance Result
 3  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here